IMPACT FACTOR
1.3
|
MNiSW
70
|
Indexed in:
ESCI
Web of Science
Clarivate Analytics
|
JCI
0.24
Journal Citation Indicator
|
CiteScore 2024
4.7
|
 | Join us at Facebook! |
4/2025
vol. 29
|
|
Review paper
Advancements and future directions of iron oxide nanoparticles in cancer therapy
Ahmed el-Mallul,
Ryszard Tomasiuk,
Piotr Jaworski,
Sadia Mughali
Contemp Oncol (Pozn) 2025; 29 (4): 323–332
Online publish date: 2025-11-05
DOI
:
https://doi.org/10.5114/wo.2025.155978
Original paper
Surgical learning curve and flap survival in head and neck
microvascular reconstruction using arterial and venous couplers
Adam Gałązka,
Karolina Bieńkowska-Pluta,
Monika Paszkowska,
Magdalena Misiak-Gałązka,
Katarzyna Stawarz
Contemp Oncol (Pozn) 2025; 29 (4): 333–340
Online publish date: 2025-10-30
DOI
:
https://doi.org/10.5114/wo.2025.155692
Original paper
DNA extraction from long-term preserved formalin-fixed paraffinembedded samples of thymic epithelial tumours – a performance comparison of three commercial kits
Duc Manh Le,
Thi Xuan Nguyen,
Thanh Chung Dang,
Ngoc Dung Tran,
Ngoc Lan Nguyen,
Thai Tra Dang,
Thu Hien Nguyen,
Huy Hoang Nguyen,
Duc Quan Nguyen,
Thi Trang Do
Contemp Oncol (Pozn) 2025; 29 (4): 341–346
Online publish date: 2025-11-11
DOI
:
https://doi.org/10.5114/wo.2025.156116
Original paper
Cancer-associated thromboses in non-small cell lung cancer patients with epidermal growth factor receptor mutation
Yosuke Maezawa,
Manato Taguchi,
Takeshi Kawakami,
Toshihide Inui,
Takeshi Numata,
Toshihiro Shiozawa,
Kunihiko Miyazaki,
Ryota Nakamura,
Takeo Endo,
Tohru Sakamoto,
Hiroaki Satoh,
Nobuyuki Hizawa
Contemp Oncol (Pozn) 2025; 29 (4): 347–353
Online publish date: 2025-10-30
DOI
:
https://doi.org/10.5114/wo.2025.155693
Original paper
The activity of pyrazoline B compound in inhibiting proliferation of breast cancer cells with human epidermal growth factor receptor 2 overexpression
Denny Satria,
Syukur Berkat Waruwu,
Eti Nurwening Sholikhah,
Mustofa Mustofa,
Pamungkas Bagus Satriyo,
Tutik Dwi Wahyuningsih,
Hesti L Wiraswati,
Muhammad Hasan Bashari,
Ema Damayanti
Contemp Oncol (Pozn) 2025; 29 (4): 360–366
Online publish date: 2025-10-30
DOI
:
https://doi.org/10.5114/wo.2025.155694
Original paper
Clinical outcomes of fractionated stereotactic radiotherapy for uveal melanoma – a Polish single-centre experience
Adam Deja,
Paulina Baluch,
Marta Wróblewska-Zierhoffer,
Emilia Zwolińska,
Maria Radomiak,
Piotr Milecki,
Iwona Rospond-Kubiak
Contemp Oncol (Pozn) 2025; 29 (4): 367–369
Online publish date: 2025-11-03
DOI
:
https://doi.org/10.5114/wo.2025.155789
Original paper
Real-world treatment patterns of hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer
Barbara Radecka,
Bogdan Żurawski,
Aleksandra Łacko,
Aleksandra Anna Grela-Wojewoda,
Karolina Wieruszewska-Kowalczyk,
Elżbieta Senkus-Konefka
Contemp Oncol (Pozn) 2025; 29 (4): 370–376
Online publish date: 2025-11-11
DOI
:
https://doi.org/10.5114/wo.2025.156076
Original paper
Immunometabolic landscape of glioblastoma – a comparative analysis of circulating cytokines and biochemical markers
Mamatova Irodakhon Yusupovna,
Ulugbekova Gulruh Juraevna,
Mamajonov Zafar Abdujalilovich,
Askarov Ibragim Rakhmonovich
Contemp Oncol (Pozn) 2025; 29 (4): 377–383
Online publish date: 2025-11-11
DOI
:
https://doi.org/10.5114/wo.2025.156117
Original paper
Real-world outcomes of immune checkpoint inhibitor monotherapy in later lines of recurrent/metastatic cervical cancer – evidence from a rescue access program in Poland
Renata Pacholczak-Madej,
Maja Lisik-Habib,
Radosław Mądry,
Monika Szarszewska,
Zuzanna Borysiewicz,
Katarzyna Gabalewicz,
Ewa Iwańska,
Wiktor Szatkowski,
Mirosława Puskulluoglu,
Jerzy Jakubowicz,
Pawel Blecharz
Contemp Oncol (Pozn) 2025; 29 (4): 384–392
Online publish date: 2025-10-28
DOI
:
https://doi.org/10.5114/wo.2025.155581
Case report
First report of refractory grey zone lymphoma in an adolescent patient treated successfully with pembrolizumab
Maria Dudzik,
Anna Zaniewska Tekieli,
Walentyna Balwierz,
Szymon Skoczeń,
Jolanta Goździk,
Malgorzata Czogala
Contemp Oncol (Pozn) 2025; 29 (4): 393–398
Online publish date: 2025-10-30
DOI
:
https://doi.org/10.5114/wo.2025.155580
|
